The liver-specific microRNA miR-122 controls systemic iron homeostasis in mice

Journal of Clinical Investigation

Volumn 121, Issue 4, 2011, Pages 1386-1396

  Castoldi, Mirco ^a   Spasic, Maja Vujic ^a   Altamura, Sandro ^a   Elmén, Joacim ^b   Lindow, Morten ^b   Kiss, Judit ^a   Stolte, Jens ^c   Sparla, Richard ^a   D'Alessandro, Lorenza A ^d   Klingmüller, Ursula ^d   Fleming, Robert E ^e   Longerich, Thomas ^a   Gröne, Hermann J ^d   Benes, Vladimir ^c   Kauppinen, Sakari ^b,f   Hentze, Matthias W ^a,c   Muckenthaler, Martina U ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Santaris Pharma AS   (Denmark)

^c EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^e SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f AALBORG UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN RECEPTOR 1A; HEMOJUVELIN; HEPCIDIN; INTERLEUKIN 6; IRON; LOCKED NUCLEIC ACID; MESSENGER RNA; MICRORNA; MICRORNA 122; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING SITE; DOWN REGULATION; EXTRAMEDULLARY HEMATOPOIESIS; FEMALE; HEMATOPOIESIS; HEMOCHROMATOSIS; HOMEOSTASIS; HUMAN; HUMAN TISSUE; INFLAMMATION; IRON BLOOD LEVEL; IRON DEFICIENCY; IRON METABOLISM; LIVER BIOPSY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN;

3' UNTRANSLATED REGIONS; ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; BINDING SITES; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE I; DOWN-REGULATION; FEMALE; GENE EXPRESSION PROFILING; HEMATOPOIESIS, EXTRAMEDULLARY; HISTOCOMPATIBILITY ANTIGENS CLASS I; HOMEOSTASIS; IRON; LIVER; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICRORNAS; OLIGONUCLEOTIDES; RNA, MESSENGER;

EID: 79953316619     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI44883     Document Type: Article

References (74)

1. Hentze MW, Muckenthaler MU, Galy B, Camaschella C. Two to tango: regulation of Mammalian iron metabolism. Cell. 2010;142(1):24-38.
2. Krause A, et al. LEAP-1, a novel highly disulfidebonded human peptide, exhibits antimicrobial activity. FEBS Lett. 2000;480(2-3):147-150.
3. Park CH, Valore EV, Waring AJ, Ganz T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem. 2001;276(11):7806-7810.
4. Nemeth E, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science. 2004;306(5704):2090-2093. (Pubitemid 40007660)
5. Finberg KE, et al. Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA). Nat Genet. 2008;40(5):569-571. (Pubitemid 351601217)
6. Pietrangelo A. Hereditary hemochromatosis. Biochim Biophys Acta. 2006;1763(7):700-710. (Pubitemid 44189549)
7. Origa R, et al. Liver iron concentrations and urinary hepcidin in beta-thalassemia. Haematologica. 2007;92(5):583-588. (Pubitemid 350144260)
8. Muckenthaler M, et al. Regulatory defects in liver and intestine implicate abnormal hepcidin and Cybrd1 expression in mouse hemochromatosis. Nat Genet. 2003;34(1):102-107. (Pubitemid 36548799)
9. Bridle KR, et al. Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis. Lancet. 2003;361(9358):669-673. (Pubitemid 36246550)
10. Papanikolaou G, et al. Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat Genet. 2004;36(1):77-82. (Pubitemid 38056211)
11. Huang FW, Pinkus JL, Pinkus GS, Fleming MD, Andrews NC. A mouse model of juvenile hemochromatosis. J Clin Invest. 2005;115(8):2187-2191. (Pubitemid 41134160)
12. Niederkofler V, Salie R, Arber S. Hemojuvelin is essential for dietary iron sensing, and its mutation leads to severe iron overload. J Clin Invest. 2005;115(8):2180-2186. (Pubitemid 41134159)
13. Camaschella C, et al. The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22. Nat Genet. 2000;25(1):14-15. (Pubitemid 30257027)
14. Fleming RE, et al. Targeted mutagenesis of the murine transferrin receptor-2 gene produces hemochromatosis. Proc Natl Acad Sci U S A. 2002; 99(16):10653-10658.
15. Andriopoulos B Jr, et al. BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism. Nat Genet. 2009;41(4):482-487.
16. Meynard D, Kautz L, Darnaud V, Canonne-Hergaux F, Coppin H, Roth MP. Lack of the bone morphogenetic protein BMP6 induces massive iron overload. Nat Genet. 2009;41(4):478-481.
17. Casanovas G, Mleczko-Sanecka K, Altamura S, Hentze MW, Muckenthaler MU. Bone morphogenetic protein (BMP)-responsive elements located in the proximal and distal hepcidin promoter are critical for its response to HJV/BMP/SMAD. J Mol Med. 2009;87(5):471-480.
18. Wang RH, et al. A role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression. Cell Metab. 2005;2(6):399-409.
19. Nemeth E, et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest. 2004;113(9):1271-1276. (Pubitemid 39069926)
20. Krutzfeldt J, Stoffel M. MicroRNAs: a new class of regulatory genes affecting metabolism. Cell Metab. 2006;4(1):9-12. (Pubitemid 43942256)
21. Meister G. miRNAs Get an Early Start on Translational Silencing. Cell. 2007;131(1):25-28.
22. Wu L, Fan J, Belasco JG. MicroRNAs direct rapid deadenylation of mRNA. Proc Natl Acad Sci U S A. 2006;103(11):4034-4039.
23. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005;120(1):15-20. (Pubitemid 40094598)
24. Sethupathy P, Corda B, Hatzigeorgiou AG. Tar- Base: A comprehensive database of experimentally supported animal microRNA targets. Rna. 2006;12(2):192-197. (Pubitemid 43121923)
25. Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W, Tuschl T. Identification of tissue- specific microRNAs from mouse. Curr Biol. 2002;12(9):735-739. (Pubitemid 34455427)
26. Landgraf P, et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell. 2007;129(7):1401-1414. (Pubitemid 46970709)
27. Padgett KA, et al. Primary biliary cirrhosis is associated with altered hepatic microRNA expression. J Autoimmun. 2009;32(3-4):246-253.
28. Kutay H, et al. Downregulation of miR-122 in the rodent and human hepatocellular carcinomas. J Cell Biochem. 2006;99(3):671-678. (Pubitemid 44521987)
29. Girard M, Jacquemin E, Munnich A, Lyonnet S, Henrion-Caude A. miR-122, a paradigm for the role of microRNAs in the liver. J Hepatol. 2008;48(4):648-656.
30. Esau C, et al. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab. 2006;3(2):87-98.
31. Elmen J, et al. Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver. Nucleic Acids Res. 2008;36(4):1153-1162. (Pubitemid 351330933)
32. Krutzfeldt J, et al. Silencing of microRNAs in vivo with 'antagomirs'. Nature. 2005;438(7068):685-689.
33. Jopling CL, Norman KL, Sarnow P. Positive and negative modulation of viral and cellular mRNAs by liver-specific microRNA miR-122. Cold Spring Harb Symp Quant Biol. 2006;71:369-376.
34. Jopling CL. Regulation of hepatitis C virus by microRNA- 122. Biochem Soc Trans. 2008;36(pt 6):1220-1223.
35. Sarasin-Filipowicz M, Krol J, Markiewicz I, Heim MH, Filipowicz W. Decreased levels of microRNA miR-122 in individuals with hepatitis C responding poorly to interferon therapy. Nat Med. 2009;15(1):31-33.
36. Vujic Spasic M, et al. Hfe acts in hepatocytes to prevent hemochromatosis. Cell Metab. 2008; 7(2):173-178. (Pubitemid 351168556)
37. Castoldi M, et al. A sensitive array for microRNA expression profiling (miChip) based on locked nucleic acids (LNA). Rna. 2006;12(5):913-920.
38. Castoldi M, Benes V, Hentze MW, Muckenthaler MU. miChip: A microarray platform for expression profiling of microRNAs based on locked nucleic acid (LNA) oligonucleotide capture probes. Methods. 2007;43(2):146-152. (Pubitemid 47419363)
39. Castoldi M, Schmidt S, Benes V, Hentze MW, Muckenthaler MU. miChip: an array-based method for microRNA expression profiling using locked nucleic acid capture probes. Nat Protoc. 2008;3(2):321-329. (Pubitemid 351266516)
40. Bala M, Sosna J, Appelbaum L, Israeli E, Rivkind AI. Enigma of primary aortoduodenal fistula. World J Gastroenterol. 2009;15(25):3191-3193.
41. Trenor CC 3rd, Campagna DR, Sellers VM, Andrews NC, Fleming MD. The molecular defect in hypotransferrinemic mice. Blood. 2000;96(3):1113-1118. (Pubitemid 30616881)
42. Brugnara C, Schiller B, Moran J. Reticulocyte hemoglobin equivalent (Ret He) and assessment of iron-deficient states. Clin Lab Haematol. 2006; 28(5):303-308. (Pubitemid 44453675)
43. Campi MG, et al. Molecular Probe Data Base (MPDB). Nucleic Acids Res. 1997;25(1):92-95. (Pubitemid 27303156)
44. Babitt JL, et al. Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nat Genet. 2006;38(5):531-539.
45. Corradini E, et al. Bone morphogenetic protein signaling is impaired in an Hfe knockout mouse model of hemochromatosis. Gastroenterology. 2009;137(4):1489-1497.
46. Kautz L, et al. BMP/Smad signaling is not enhanced in Hfe-deficient mice despite increased Bmp6 expression. Blood. 2009;114(12):2515-2520.
47. Wallace DF, Summerville L, Crampton EM, Frazer DM, Anderson GJ, Subramaniam VN. Combined deletion of Hfe and transferrin receptor 2 in mice leads to marked dysregulation of hepcidin and iron overload. Hepatology. 2009;50(6):1992-2000.
48. Kautz L, et al. Iron regulates phosphorylation of Smad1/5/8 and gene expression of Bmp6, Smad7, Id1, and Atoh8 in the mouse liver. Blood. 2008;112(4):1503-1509.
49. John B, Enright AJ, Aravin A, Tuschl T, Sander C, Marks DS. Human MicroRNA targets. PLoS Biol. 2004;2(11):e363.
50. Krek A, et al. Combinatorial microRNA target predictions. Nat Genet. 2005;37(5):495-500. (Pubitemid 40617277)
51. Friedman JM, et al. The putative tumor suppressor microRNA-101 modulates the cancer epigenome by repressing the polycomb group protein EZH2. Cancer Res. 2009;69(6):2623-2629.
52. Miranda KC, et al. A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes. Cell. 2006;126(6):1203-1217. (Pubitemid 44380294)
53. Dore LC, et al. A GATA-1-regulated microRNA locus essential for erythropoiesis. Proc Natl Acad Sci U S A. 2008;105(9):3333-3338. (Pubitemid 351723553)
54. Pase L, Layton JE, Kloosterman WP, Carradice D, Waterhouse PM, Lieschke GJ. miR-451 regulates zebrafish erythroid maturation in vivo via its target gata2. Blood. 2009;113(8):1794-1804.
55. Rasmussen KD, et al. The miR-144/451 locus is required for erythroid homeostasis. J Exp Med. 2010;207(7):1351-1358.
56. Verga Falzacappa MV, Vujic Spasic M, Kessler R, Stolte J, Hentze MW, Muckenthaler MU. STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation. Blood. 2007;109(1):353-358. (Pubitemid 46053077)
57. Wrighting DM, Andrews NC. Interleukin-6 induces hepcidin expression through STAT3. Blood. 2006;108(9):3204-3209.
58. Silvestri L, Pagani A, Nai A, De Domenico I, Kaplan J, Camaschella C. The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin. Cell Metab. 2008; 8(6):502-511.
59. Mleczko-Sanecka K, et al. SMAD7 controls iron metabolism as a potent inhibitor of hepcidin expression. Blood. 2010;115(13):2657-2665.
60. Gatfield D, et al. Integration of microRNA miR- 122 in hepatic circadian gene expression. Genes Dev. 2009;23(11):1313-1326.
61. Marro S, et al. Heme controls ferroportin1 (FPN1) transcription involving Bach1, Nrf2 and a MARE/ ARE sequence motif at position -7007 of the FPN1 promoter. Haematologica. 2010;95(8):1261-1268.
62. Noyes HA, et al. Mechanisms controlling anaemia in Trypanosoma congolense infected mice. PLoS One. 2009;4(4):e5170.
63. Elmen J, et al. LNA-mediated microRNA silencing in non-human primates. Nature. 2008; 452(7189):896-899. (Pubitemid 351550859)
64. Lanford RE, et al. Therapeutic silencing of microRNA- 122 in primates with chronic hepatitis C virus infection. Science. 2010;327(5962):198-201.
65. Shan Y, Zheng J, Lambrecht RW, Bonkovsky HL. Reciprocal effects of micro-RNA-122 on expression of heme oxygenase-1 and hepatitis C virus genes in human hepatocytes. Gastroenterology. 2007;133(4):1166-1174.
66. Schmidt PJ, Toran PT, Giannetti AM, Bjorkman PJ, Andrews NC. The transferrin receptor modulates Hfe-dependent regulation of hepcidin expression. Cell Metab. 2008;7(3):205-214. (Pubitemid 351285524)
67. Rodriguez A, Luukkaala T, Fleming RE, Britton RS, Bacon BR, Parkkila S. Global transcriptional response to Hfe deficiency and dietary iron overload in mouse liver and duodenum. PLoS One. 2009;4(9):e7212.
68. Torrance JD, Bothwell TH. A simple technique for measuring storage iron concentrations in formalinised liver samples. S Afr J Med Sci. 1968;33(1):9-11.
69. Vujic Spasic M, et al. Physiologic systemic iron metabolism in mice deficient for duodenal Hfe. Blood. 2007;109(10):4511-4517.
70. Hellemans J, Mortier G, De Paepe A, Speleman F, Vandesompele J. qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol. 2007;8(2):R19.
71. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402-408. (Pubitemid 34164012)
72. Muckenthaler M, et al. Relationships and distinctions in iron-regulatory networks responding to interrelated signals. Blood. 2003;101(9):3690-3698. (Pubitemid 36857961)
73. Barrett T, Edgar R. Gene expression omnibus: microarray data storage, submission, retrieval, and analysis. Methods Enzymol. 2006;411:352-369. (Pubitemid 44291435)
74. Klingmuller U, et al. Primary mouse hepatocytes for systems biology approaches: a standardized in vitro system for modelling of signal transduction pathways. Syst Biol (Stevenage). 2006;153(6):433-447. (Pubitemid 44712259)